Stuart Benjamin, “The First Amendment and Algorithms,” in The Cambridge Handbook of the Law of Algorithms 606–631 (Woodrow Barfield, ed., 2021). »Read the chapter

M. Andrews, A. Chatterji, S. Stern, “Beyond 140 Characters: Introduction to the Role of Innovation and Entrepreneurship in Economic Growth,” NBER Working Paper (Nov. 2020). »Read the article

Arti K. Rai, Isha Sharma, & Christina Silcox, “Accountability, Secrecy, and Innovation in AI-Enabled Clinical Decision Software,” Journal of Law and the Biosciences, November 14, 2020. »Read the article

A. Arora, S. Belenzon, A. Patacconi, “Knowledge sharing in alliances and alliance portfolios,” Management Science (Aug. 2020). »Read the article

W. Nicholson Price II, Arti K. Rai, & Timo Minssen, “Knowledge Transfer for Large-Scale Vaccine Manufacturing,” Science, August 21, 2020. »Read the article

Lawrence O. Gostin & Arti K. Rai, “Expanding Access and Reducing Prices for Drugs to Prevent HIV: Should Government Enforce Its Patent Rights Against the Pharmaceutical Industry?,” JAMA Network, March 3, 2020. »Read the article

Arti K. Rai, “In the Constitutional Cross-Hairs: PTAB Judges and Administrative Jurisdiction,” Patently-O, Nov. 4, 2019. »Read the article

W. Nicholson Price II & Arti K. Rai, “How logically impossible patents block biosimilars,” Nature Biotechnology 37:862–863 (2019). »Read the article

Michael D. Frakes, Jonathan Gruber, and Anupam Jena, “Is Great Information Good Enough? Evidence from Physicians as Patients,” NBER Working Paper #26038, July 2019. »Read the paper

Arti K. Rai, “Machine Learning at the Patent Office: Lessons from Patents and Administrative Law,” May 24, 2019. »Read the paper

Michael Frakes and Melissa F. Wasserman, “Irrational Ignorance at the Patent Office,” Vanderbilt Law Review, 72:3:975–1030, April 2019. »Read the article

Aaron Chatterji, The Main Street Fund: Investing in an Entrepreneurial Economy, Policy Proposal 2018-09, Hamilton Project, Brookings Institution, June 2018. »Read the full paper

Arti K. Rai and Barak D. Richman, “A Preferable Path for Thwarting Pharmaceutical Product Hopping,” Health Affairs Blog, May 22, 2018. »Read the article

Ashish Arora, Sharon Belenzon, and A. Patacconi, “The Decline of Science in Corporate R&D,” Strategic Management, 39:1:3–32, January 2018. »Read the article